PHARMACY PRACTICE-BIOSIMILARS
Do you support it?
Want to know if it passes?
We'll email you when SB 1934 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on SB 1934.
You're tracking SB 1934
We'll email you the moment it moves.
SB 1934 — PHARMACY PRACTICE-BIOSIMILARS
Last action — Session Sine Die
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 98th Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Amends the Pharmacy Practice Act. Provides that a pharmacist may substitute a prescription biosimilar product for a prescribed biological product under certain circumstances. Provides that the Board shall adopt rules for compliance with these provisions. Effective immediately.
Bill Text
- Introduced View text Current html
Action History
-
Session Sine Die
-
Pursuant to Senate Rule 3-9(b) / Referred to Assignments
-
Rule 2-10 Committee/3rd Reading Deadline Established As November 7, 2013
-
Rule 2-10 Third Reading Deadline Established As May 31, 2013
-
Rule 2-10 Third Reading Deadline Established As May 3, 2013
-
Placed on Calendar Order of 3rd Reading April 25, 2013
-
Second Reading
-
Placed on Calendar Order of 2nd Reading March 21, 2013
-
Do Pass Executive; 011-003-000
-
Sponsor Removed Sen. Steven M. Landek
-
Postponed - Executive
-
Sponsor Removed Sen. Mike Jacobs
-
Added as Co-Sponsor Sen. Dan Kotowski
-
Added as Co-Sponsor Sen. Mattie Hunter
-
Sponsor Removed Sen. William Delgado
-
Assigned to Executive
-
Added as Co-Sponsor Sen. Steven M. Landek
-
Added as Co-Sponsor Sen. William Delgado
-
Added as Co-Sponsor Sen. Mike Jacobs
-
Added as Co-Sponsor Sen. David Koehler
-
Added as Chief Co-Sponsor Sen. Melinda Bush
-
Added as Chief Co-Sponsor Sen. Pamela J. Althoff
-
Added as Chief Co-Sponsor Sen. Iris Y. Martinez
-
Referred to Assignments
-
First Reading
-
Filed with Secretary by Sen. Antonio Muñoz
Sponsors
- Antonio Muñoz · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →0 sponsors · 1 co-sponsors · 182 not signed on
Sponsors (0)
None.
Co-sponsors (1)
- Antonio Muñoz
Not signed on (182)
182 members have not signed on to this bill.
Show all 182 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 1934 do?
- Amends the Pharmacy Practice Act. Provides that a pharmacist may substitute a prescription biosimilar product for a prescribed biological product under certain circumstances. Provides that the Board shall adopt rules for compliance with these provisions. Effective immediately.
- Who sponsors SB 1934?
- SB 1934 is sponsored by Antonio Muñoz.
- What is the current status of SB 1934?
- This bill died with 98th Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SB 1934?
- Track SB 1934 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 1934
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 1934
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →